Opinion|Videos|November 25, 2025
The Burden and Unmet Needs Associated with Desmoid Tumors
Patients with desmoid tumors face significant clinical and economic burdens, impacting their quality of life and leading to ongoing treatment challenges.
Advertisement
Episodes in this series
Panelists discuss the questions below in this video.
- There any molecular biomarkers that are commonly associated with desmoid tumor?
- What is the role of biomarker testing in patients with suspected diagnosis? What makes the definitive diagnosis?
Newsletter
Stay ahead of policy, cost, and value—subscribe to AJMC for expert insights at the intersection of clinical care and health economics.
Advertisement
Related Content
Advertisement
Advertisement
Advertisement
Trending on AJMC
1
ctDNA Positivity Associated With Worse Survival, Higher Recurrence Risk in Patients With NSCLC
2
Novel CLL Therapies Prompt New Treatment Considerations
3
Teclistamab Transforms Early Myeloma Care: Roberto Mina, MD
4
Balancing Innovation With Administrative Burdens in Cancer Care
5
